Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks

2 Jun 2008

Abstract excerpt

OBJECTIVE: Trisomy 21 is associated with a flat face, which can now be quantified by measurement of the frontomaxillary facial (FMF) angle. The aim of this study was to examine whether in trisomy 21 fetuses fetal nuchal translucency (NT) thickness and maternal serum free ss-human chorionic gonadotropin (ss-hCG) and pregnancy-associated plasma protein-A (PAPP-A) are independent of the FMF angle, and to estimate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18512854
DOI: 10.1002/uog.5334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeksPMID 18512854Read ↗

Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks’ gestationSemantic proximity Read ↗

Frontomaxillary and mandibulomaxillary facial angles at 11 + 0 to 13 + 6 weeks in fetuses with trisomy 18Semantic proximity Read ↗

Application of an individualized nomogram in first‐trimester screening for trisomy 21Semantic proximity Read ↗

Absence of fetal nasal bone and aneuploidies at first‐trimester nuchal translucency screening in unselected pregnanciesSemantic proximity Read ↗

Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestationSemantic proximity Read ↗

A mixture model of nuchal translucency thickness in screening for chromosomal defectsSemantic proximity Read ↗

A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐ASemantic proximity Read ↗

Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancySemantic proximity Read ↗

First‐trimester crown–rump length and embryonic volume of aneuploid fetuses measured in virtual realitySemantic proximity Read ↗

Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14‐week scanSemantic proximity Read ↗

A novel artificial intelligence model for fetal facial profile marker measurement during the first trimesterSemantic proximity Read ↗

Nuchal translucency measurement in normal fetusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.